Terms: = Leukemia AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB AND Treatment
15 results:
1. Systems Biology for Drug Target Discovery in Acute Myeloid leukemia.
Novikova S; Tolstova T; Kurbatov L; Farafonova T; Tikhonova O; Soloveva N; Rusanov A; Zgoda V
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731835
[TBL] [Abstract] [Full Text] [Related]
2. Bioactive triterpenoid compounds of Poria cocos (Schw.) Wolf in the treatment of diabetic ulcers via regulating the PI3K-AKT signaling pathway.
Ding X; Li S; Huang H; Shen J; Ding Y; Chen T; Ma L; Liu J; Lai Y; Chen B; Wang Y; Tan Q
J Ethnopharmacol; 2024 May; 325():117812. PubMed ID: 38301984
[TBL] [Abstract] [Full Text] [Related]
3. Cordycepin improves sensitivity to temozolomide in glioblastoma cells by down-regulating MYC.
Zheng SX; Chen J; Zhuang BB; Zhang Q; Shi SS; Zhang GL
J Cancer Res Clin Oncol; 2023 Nov; 149(17):16055-16067. PubMed ID: 37695389
[TBL] [Abstract] [Full Text] [Related]
4. β-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia.
García-Hernández V; Arambilet D; Guillén Y; Lobo-Jarne T; Maqueda M; Gekas C; González J; Iglesias A; Vega-García N; Sentís I; Trincado JL; Márquez-López I; Heyn H; Camós M; Espinosa L; Bigas A
EMBO Mol Med; 2023 Feb; 15(2):e16554. PubMed ID: 36597789
[TBL] [Abstract] [Full Text] [Related]
5. Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors.
Braggio DA; Costas C de Faria F; Koller D; Jin F; Zewdu A; Lopez G; Batte K; Casadei L; Welliver M; Horrigan SK; Han R; Larson JL; Strohecker AM; Pollock RE
PLoS One; 2022; 17(10):e0276047. PubMed ID: 36240209
[TBL] [Abstract] [Full Text] [Related]
6. Bone marrow mesenchymal stromal cells in chronic myelomonocytic leukaemia: overactivated WNT/β-catenin signalling by parallel RNA sequencing and dysfunctional phenotypes.
Xu R; Huang X; Li C; Deng C; Li M; Wu P; Geng S; Lai P; Lu Z; Weng J; Du X
Br J Haematol; 2021 Jun; 193(5):928-940. PubMed ID: 33959953
[TBL] [Abstract] [Full Text] [Related]
7. Double and single mixed-lineage leukemia-rearranged subclones in pediatric acute myeloid leukemia: a case report.
McGrath M; Smink G
J Med Case Rep; 2021 May; 15(1):228. PubMed ID: 33957966
[TBL] [Abstract] [Full Text] [Related]
8. TCF7 knockdown inhibits the imatinib resistance of chronic myeloid leukemia K562/G01 cells by neutralizing the Wnt/β‑catenin/TCF7/ABC transporter signaling axis.
Zhang H; Wang Y; Yang H; Huang Z; Wang X; Feng W
Oncol Rep; 2021 Feb; 45(2):557-568. PubMed ID: 33416164
[TBL] [Abstract] [Full Text] [Related]
9. Molecular genetics and targeted therapy of WNT-related human diseases (Review).
Katoh M; Katoh M
Int J Mol Med; 2017 Sep; 40(3):587-606. PubMed ID: 28731148
[TBL] [Abstract] [Full Text] [Related]
10. [Genetic Polymorphisms in Wnt Signaling Pathway and Acute leukemia].
Zhang LJ; Zhou J; Ye YX; Lu XJ; Jiang H; Mao ZG; Zeng SG; Ying BW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 May; 46(3):403-8. PubMed ID: 26121862
[TBL] [Abstract] [Full Text] [Related]
11. LGR5 is a biomarker for stratification of HER-2 positive breast cancer patients and personalized treatment.
Chen C; Zhang C; Xu JM; Han Y
Med Hypotheses; 2013 Sep; 81(3):439-42. PubMed ID: 23830593
[TBL] [Abstract] [Full Text] [Related]
12. Identification of driver genes in hepatocellular carcinoma by exome sequencing.
Cleary SP; Jeck WR; Zhao X; Chen K; Selitsky SR; Savich GL; Tan TX; Wu MC; Getz G; Lawrence MS; Parker JS; Li J; Powers S; Kim H; Fischer S; Guindi M; Ghanekar A; Chiang DY
Hepatology; 2013 Nov; 58(5):1693-702. PubMed ID: 23728943
[TBL] [Abstract] [Full Text] [Related]
13. Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia cells.
Minke KS; Staib P; Puetter A; Gehrke I; Gandhirajan RK; Schlösser A; Schmitt EK; Hallek M; Kreuzer KA
Eur J Haematol; 2009 Mar; 82(3):165-75. PubMed ID: 19067737
[TBL] [Abstract] [Full Text] [Related]
14. The risk of developing second cancers among survivors of childhood soft tissue sarcoma.
Cohen RJ; Curtis RE; Inskip PD; Fraumeni JF
Cancer; 2005 Jun; 103(11):2391-6. PubMed ID: 15852362
[TBL] [Abstract] [Full Text] [Related]
15. [The results of prostatic adenomectomy in patients with severe concomitant diseases].
Vagner EA; Goriunov VG; Davidov MI
Khirurgiia (Mosk); 1998; (8):40-4. PubMed ID: 9753937
[TBL] [Abstract] [Full Text] [Related]
